A plan by the four major units of Formosa Plastics Group (FPG, 台塑集團) to lower their stakes in a steel mill in Vietnam reflects the group’s caution about global demand, analysts said yesterday.
“As China, one of the world’s largest steel buyers, will no longer pursue high economic growth, global steel demand could slow down accordingly,” Hua Nan Securities (華南永昌證券) analyst Henry Miao (苗台生) said.
In the second quarter, China’s economy grew 7.5 percent year-on-year, slowing from a 7.7 percent increase in the first quarter.
Beijing expects GDP this year to grow by 7.5 percent, compared with a 7.7 percent increase recorded last year. Chinese authorities have said the country wants a more balanced economy rather than simply seeking high GDP growth.
“I think FPG has taken possible lower demand from China into account and decided to cut its stake in the steel investment project in Vietnam,” Miao said.
The group’s four major units — Formosa Plastics Corp (台塑), Nan Ya Plastics Corp (南亞塑膠), Formosa Chemicals & Fibre Corp (台灣化纖) and Formosa Petrochemical Corp (台塑石化) — said on Thursday that they each decided to cut stakes in Formosa Ha Tinh Steel Corp (台塑河靜鋼鐵興業) to 14.75 percent from 21.25 percent.
Before the adjustments, the subsidiaries had poured US$744 million each into the
Vietnam steel project, which is still under construction. It is scheduled to become operational in the second half of 2015 with an annual production capacity of 7 million tonnes.
After the reductions, the four investments in the Vietnam project are expected to be worth US$516 million each.
The group said the four subsidiaries are expected to see their financial burdens eased due to the smaller investments. It added that because steel production is not their core business, they aim to introduce partners in the global steel industry to help them push the Vietnam project forward.
Media reports said FPG plan to introduce foreign partners such as Nippon Steel Corp to the project.
MOVING ON UP: Taiwan improved in all four areas measured by the IMD, making its biggest leap, from 17th to sixth place, in economic performance Taiwan moved up three spots from last year to place eighth, its best performance since 2013, in the latest annual world competitiveness rankings, released yesterday by the International Institute for Management Development (IMD). Innovation, digitalization, welfare benefits and social cohesion are critical to economic performance, with Switzerland, Sweden, Denmark, the Netherlands and Singapore making up the top five on the list this year, the Switzerland-based institute said, after grading 64 countries and regions based on economic performance, infrastructure, and government and business efficiency. “Leading performers are characterized by varying degrees of investment in innovation, diversified economic activities and supportive public policy,” IMD
With the US opening up to travel, demand in Taiwan for US-bound flights has soared, pushing up ticket prices to most destinations in North America, tourism sources said. Fares for destinations in the US have risen dramatically since the middle of last month, and the trend is expected to continue in the coming months, as California on Tuesday lifted most social distancing and capacity limits put in place to contain the spread of COVID-19, ezTravel Co (易遊網) said in a statement yesterday. The travel agency forecast that the number of tickets sold this month is likely to be double or triple
‘MATTER OF SURVIVAL’: Vice Premier Liu He is to lead the development of ‘third-generation’ chips, a field not yet dominated by any nation or company Chinese President Xi Jinping (習近平) is renewing his years-long push to achieve technology self-sufficiency by tapping a top deputy to shepherd a key initiative aimed at helping domestic chipmakers overcome US sanctions. Chinese Vice Premier Liu He (劉鶴), Xi’s economic czar whose sprawling portfolio spans trade to finance and technology, has been tapped to spearhead the development of so-called “third-generation” chip development and capabilities, and is leading the formulation of a series of financial and policy supports for the technology, people with knowledge of the matter said. It is a nascent field that relies on newer materials and gear beyond traditional silicon,
OPPORTUNITY: The company aims to sell its product soon, as enterovirus vaccines are not available anywhere but China, where firms are only marketing their vaccines locally Medigen Vaccine Biologics Corp’s (高端疫苗) phase 3 clinical trials for an enterovirus 71 (EV71) vaccine completed the multi-regional, multi-central data “unblinding” yesterday, with the results, including safety, immunogenicity and efficacy, meeting its expectations. The company would compile a final analysis report as soon as possible, and apply for the new drug certificate from domestic and foreign drug authorities in the third quarter, Medigen said in a Taiwan Stock Exchange filing yesterday. Its phase 3 trials were conducted in Taiwan and Vietnam with 3,049 participants ranging from two months old to six years old, Medigen said. The company enrolled its first participant for